Single FrAction Interstitial BreaSt BracHytherApy
ConditionBreast Cancer
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age40-85
SponsorVirginia Commonwealth University
About this trial
This phase 2, single arm prospective study has been designed to determine the safety of delivering accelerated partial breast irradiation (APBI) with a multicatheter interstitial implant in a single fraction over 1 day. This is a method of delivering radiation therapy directly into or close to a tumor.
Eligibility criteria
Qualifiers
Female
New diagnosis of Ductal Carcinoma in Situ (DCIS) and/or invasive breast carcinoma per histologic evaluation
Age 40-85 at diagnosis
Previous lumpectomy with surgical margins histologically free of invasive tumor and DCIS as determined by the pathologist
Disqualifiers
Pregnant or breastfeeding
Active collagen-vascular disease
Paget's disease of the breast
Any prior history of DCIS or invasive breast cancer prior to the current diagnosis
Trial design
Treatments tested in this trial
- Partial Breast Irradiation
Treatment groups
134 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov